ORION BIOTECH OPPORTUNTES CO's ticker is and the CUSIP is G6780C109. A total of 53 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $6,323,641 | +1.3% | 629,218 | -0.8% | 0.04% | +5.7% |
Q3 2022 | $6,241,000 | +1.1% | 634,222 | -0.0% | 0.04% | -7.9% |
Q2 2022 | $6,176,000 | -0.1% | 634,368 | -0.1% | 0.04% | -26.9% |
Q1 2022 | $6,184,000 | +0.7% | 634,898 | -0.0% | 0.05% | -10.3% |
Q4 2021 | $6,142,000 | – | 635,053 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
683 Capital Management, LLC | 1,199,000 | $11,798,000 | 0.91% |
Atalaya Capital Management LP | 500,000 | $4,930,000 | 0.67% |
MMCAP International Inc. SPC | 800,000 | $7,872,000 | 0.62% |
ANGELO GORDON & CO., L.P. | 300,000 | $2,952,000 | 0.53% |
Arena Capital Advisors, LLC- CA | 141,317 | $1,393,000 | 0.42% |
DG Capital Management, LLC | 94,629 | $933,000 | 0.41% |
KIM, LLC | 800,000 | $7,888,000 | 0.37% |
FIR TREE CAPITAL MANAGEMENT LP | 953,603 | $9,403,000 | 0.32% |
P SCHOENFELD ASSET MANAGEMENT LP | 500,000 | $4,928,000 | 0.27% |
Exos TFP Holdings LLC | 43,165 | $425,000 | 0.20% |